| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AERIE PHARMACEUTICALS INC | 1,697,884 | 64,078,000 | 29.95% | ||
| 2 | ALDER BIOPHARMACEUTICALS INC | 1,585,683 | 51,963,000 | 24.29% | ||
| 3 | WAVE LIFE SCIENCES LTD | 727,496 | 23,622,000 | 11.04% | ||
| 4 | AIMMUNE THERAPEUTICS INC COM | 935,020 | 14,025,000 | 6.56% | ||
| 5 | INTELLIA THERAPEUTICS INC | 763,688 | 12,998,000 | 6.08% | ||
| 6 | GLOBAL BLOOD THERAPEUTICS IN COM | 455,590 | 10,501,000 | 4.91% | ||
| 7 | NANOSTRING TECHNOLOGIES INC | 485,600 | 9,702,000 | 4.53% | ||
| 8 | Momenta Pharmaceuticals Inc | 595,513 | 6,962,000 | 3.25% | ||
| 9 | Protagonist Therapeutics, Inc. | 346,281 | 6,285,000 | 2.94% | ||
| 10 | EPIZYME INC COM | 611,777 | 6,020,000 | 2.81% | ||
| 11 | ZAFGEN INC COM | 537,495 | 1,779,000 | 0.83% | ||
| 12 | AKARI THERAPEUTICS PLC | 197,072 | 1,677,000 | 0.78% | ||
| 13 | LIPOCINE INC NEW | 302,640 | 1,350,000 | 0.63% | ||
| 14 | Audentes Therapeutics, Inc. | 66,553 | 1,185,000 | 0.55% | ||
| 15 | Orexigen Therapeutics, Inc. | 254,257 | 844,000 | 0.39% | ||
| 16 | SYROS PHARMACEUTICALS INC | 60,000 | 832,000 | 0.39% | ||
| 17 | BioDelivery Sciences International Inc | 47,158 | 127,000 | 0.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-133777, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
